WASHINGTON (dpa-AFX) - Patients using the Boston Scientific Corp. (BSX) LATITUDE Remote Patient Management system with wireless telemetry demonstrated significantly lower mortality and fewer hospitalizations than patients with LATITUDE-compatible devices who were not followed on the system, according to results from the PREDICt-RM study or Patient RElated Determinants of ICDRemote Monitoring Utilization and Outcomes.
PREDICt-RM demonstrated a 33 percent relative reduction in the risk of death in patients with Boston Scientific ICDs and CRT-Ds who were remotely monitored via the LATITUDE wireless remote monitoring system, compared to Boston Scientific ICD and CRT-D patients who were not remotely monitored. Additionally, these patients experienced a 19 percent relative reduction in hospitalizations for any cause.
The LATITUDE Remote Patient Management system connects a home communicator to the patient's implanted Boston Scientific device through wireless telemetry, enabling automatic collection of patient data. The system capabilities include transmitting physiologic data, as well as data gathered from the implanted device to the healthcare team's LATITUDE website.
Boston Scientific provides wireless telemetry across all pacemaker, ICD, and CRT-D implantable devices. The LATITUDE system is the only implanted-device monitoring system with integrated physiologic monitoring of weight and blood pressure in the United States.
Copyright RTT News/dpa-AFX
© 2014 AFX News
